MedTrace Logo

To Study the Effect of SC-FOS Prebiotics in Women With Polycystic Ovary Syndrome

NCT05999097 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-02-05

No results posted yet for this study

Summary

The purpose of this study is to determine if there is a difference in the clinical characteristics of patients with polycystic ovary syndrome after the administration of SC-FOS in the enteral diet compared to patients with a standard diet.

Conditions

  • Polycystic Ovary Syndrome

Interventions

DIETARY_SUPPLEMENT

Short Chain Fructooligosaccharides

The intervention will receive Short-Chain Fructooligosaccharides at a dose of 12 gr. every 24 hours diluted in 250 ml of water.

DIETARY_SUPPLEMENT

Placebo Group

This group will receive 12 g of corn starch as a control group.

Sponsors & Collaborators

  • Universidad Autonoma de Chihuahua

    lead OTHER

Principal Investigators

  • Luis B Enríquez-Sánchez · Universidad Autonoma de Chihuahua

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-02
Primary Completion
2025-05-10
Completion
2025-05-30

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05999097 on ClinicalTrials.gov